Tardive neurotoxicity of anticholinergic drugs: A review

Abstract

The cholinergic system is a complex neurotransmitter system with functional involvement at multiple levels of the nervous system including the cerebral cortex, spinal cord, autonomic nervous system, and neuromuscular junction. Anticholinergic medications are among the most prescribed medications, making up one‐third to one‐half of all medications prescribed for seniors. Recent evidence has linked long‐term use of anticholinergic medications and dementia. Emerging evidence implicates the cholinergic system in the regulation of cerebral vasculature as well as neuroinflammation, suggesting that anticholinergic medications may contribute to absolute risk and progression of neurodegenerative diseases. In this review, we explore the involvement of the cholinergic system in various neurodegenerative diseases and the possible detrimental effects of anticholinergic medications on the onset and progression of these disorders. We identified references by searching the PubMed and Cochrane database between January 1990 and September 2019 for English‐language animal and human studies including randomized clinical trials (RCTs), meta‐analyses, systematic reviews, and observational studies. In addition, we conducted a manual search of reference lists from retrieved studies. Long‐term anticholinergic medication exposure may have detrimental consequences beyond well‐documented short‐term cognitive effects, through a variety of mechanisms either directly impacting cholinergic neurotransmission or through receptors expressed on the vasculature or immune cells, providing a pathophysiological framework for complex interactions across the entire neuroaxis.

Imperative Role of Machine Learning Algorithm for Detection of Parkinson’s Disease: Review, Challenges and Recommendations

“…The function of the neurotransmitter acetylcholine (ACh) in the central and autonomic nervous systems is blocked by anticholinergic medicines, which leads to a wide range of both beneficial and undesirable consequences. Since many of the most often given medications for seniors are indicated for problems common to the age, one-third to one-half of these medications contain anticholinergic effects [ 32 ]. These medications are particularly effective in treating tremors, stiffness of the muscles, and antidepressants Parkinsonism.…”

The Attenuating Effect of Beta-Carotene on Streptozotocin Induced Diabetic Vascular Dementia Symptoms in Rats

“…Impairment of the cholinergic system was evident in studies of VaD [18,22,23], where there was deafferentation of frontal and limbic cortical structures, as well as disturbance of basal ganglia, thalamus, white matter and sub frontal areas [24]. In VaD, there are loss of cholinergic neurons, reduced choline acetyltransferase (ChAT) activity, decrement in m3 and m5 muscarinic acetylcholine (ACh) receptor expression, lowered ACh level and worsened memory and learning [25].…”

A Computerized Analysis with Machine Learning Techniques for the Diagnosis of Parkinson’s Disease: Past Studies and Future Perspectives

“…The function of the neurotransmitter acetylcholine (ACh) in the central and autonomic nervous systems is blocked by anticholinergic medicines, which leads to a wide range of both beneficial and undesirable consequences. Since many of the most often given medications for seniors are indicated for problems common to the aged, one-third to one-half of these medications contain anticholinergic effects [ 107 ]. These medications are particularly effective in treating tremors, stiffness of the muscles, and antidepressants for Parkinsonism.…”